Drug Profile
BMS 776532
Alternative Names: BMS-776532Latest Information Update: 03 Oct 2023
Price :
$50
*
At a glance
- Originator Bristol-Myers Squibb
- Class Anti-inflammatories; Pyridines; Thiadiazoles; Xanthenes
- Mechanism of Action Glucocorticoid receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Inflammation
Most Recent Events
- 03 Oct 2023 Discontinued - Preclinical for Inflammation in USA (unspecified route)
- 28 Mar 2019 No recent reports of development identified for preclinical development in Inflammation in USA
- 31 Jul 2017 Chemical structure information added